Dornase alfa
 | This article needs more primary sources. (February 2022) |  |
| Clinical data | |
|---|---|
| Trade names | Pulmozyme |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a694002 |
| License data |
|
| Pregnancy category |
|
Inhalation | |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
ECHA InfoCard | 100.029.685 |
| Chemical and physical data | |
| Formula | C1321H1999N339O396S9 |
| Molar mass | 29254.04 g·mol−1 |
  (what is this?) (verify) | |
Dornase alfa, sold under the brand name Pulmozyme, is used for the treatment of
Chinese hamster ovary cells.[3]
Medical uses
Dornase alfa is
indicated for the management of people with cystic fibrosis to improve pulmonary function.[3]
Society and culture
Legal status
Dornase alfa is an orphan drug.[4]
Research
Dornase alfa has been shown to improve lung function in non-cystic fibrosis pre-term infants atelectasis.[5][6]
